About this item:

425 Views | 0 Downloads

Author Notes:

Haimanot Wasse, MD, MPH, Emory University, Renal Division, Woodruff Memorial Building, Room 338, 1630 Pierce Drive, Atlanta, GA 30322 (USA), Tel. +1 404 727 1598, E-Mail hwasse@emory.edu

The conclusions and opinions expressed, and methods used herein are those of the authors.

They do not necessarily reflect CMS policy.

The authors assume full responsibility for the accuracy and completeness of the ideas presented.

Subject:

Research Funding:

This work was supported in part by a National Institutes of Health Career Development Award K23 DK65634 (H.W.).

The analyses upon which this publication is based were performed under Contract No. 500-96-P704, entitled ‘Operation Utilization and Quality Control Peer Review Organization for the State of Georgia,’ sponsored by CMS, Department of Health and Human Services.

Keywords:

  • Adequacy of care
  • Chronic kidney disease
  • Vascular access

Racial and Gender Differences in Arteriovenous Fistula Use among Incident Hemodialysis Patients

Tools:

Journal Title:

American Journal of Nephrology

Volume:

Volume 32, Number 3

Publisher:

, Pages 234-241

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Background Arteriovenous fistula (AVF) use is reported to differ among racial and gender groups. We sought to identify risk factors associated with incident AVF and whether racial and gender differences in AVF use persist after controlling for these factors. Methods We evaluated 28,712 incident adult hemodialysis patients (age ≥18) from five ESRD networks starting dialysis between June 1, 2005 and May 31, 2006. Data were obtained from the Center for Medicaid and Medicare Services 2728 form. Results Incident AVF use was reported for 11% of black and 12% of white patients [OR = 0.89 (95% CI: 0.83, 0.96)], and for 9% of females and 13% of males [OR = 0.66 (0.62–0.71)]. After adjusting for facility clustering, blacks were as likely as whites to use an AVF [OR = 1.00 (0.92–1.09)], while gender differences persisted [OR = 0.64 (0.59–0.69)]. Compared to patients with no renal care prior to dialysis initiation, incident AVF use was 16-fold greater among those with ≥12 months of nephrology care [OR = 15.99 (13.25–19.29)], 9-fold greater among those with 6–12 months of care [OR = 9.00 (7.45–10.88)] and 7-fold greater among those with at least 6 months of care [OR = 7.13 (5.73–8.88)]. Conclusion Racial, but not gender, differences in incident AVF use were eliminated after accounting for clustering within facilities.

Copyright information:

© 2010 by S. Karger AG, Basel

Export to EndNote